These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3810552)

  • 21. Circadian variations in coagulation and fibrinolytic factors among four different strains of mice.
    Ohkura N; Oishi K; Sakata T; Kadota K; Kasamatsu M; Fukushima N; Kurata A; Tamai Y; Shirai H; Atsumi G; Ishida N; Matsuda J; Horie S
    Chronobiol Int; 2007; 24(4):651-69. PubMed ID: 17701678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
    Moreno JA; Gálvez MM; Cornudella R; Angós JA; Romero MS; Gutiérrez M
    Sangre (Barc); 1994 Apr; 39(2):111-6. PubMed ID: 8059288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Components of the fibrinolytic system of Guerin's epithelioma].
    Zurawski P; Zagórska M; Grygoruk M; Worowski K
    Acta Haematol Pol; 1985; 16(3-4):151-7. PubMed ID: 3835771
    [No Abstract]   [Full Text] [Related]  

  • 24. Abnormalities of fibrinolysis in essential hypertension.
    Ettenger MM; MacCarthy EP; Glas-Greenwalt P; Clyne DH; Pollak VE
    J Hypertens Suppl; 1984 Dec; 2(3):S175-8. PubMed ID: 6242555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma tissue factor antigen in localized prostate cancer: distribution, clinical significance and correlation with haemostatic activation markers.
    Langer F; Chun FK; Amirkhosravi A; Friedrich M; Leuenroth S; Eifrig B; Bokemeyer C; Francis JL
    Thromb Haemost; 2007 Mar; 97(3):464-70. PubMed ID: 17334515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occurrence of components of fibrinolytic pathways in situ in laryngeal cancer.
    Wojtukiewicz MZ; Sierko E; Zacharski LR; Rózanska-Kudelska M; Zimnoch L
    Semin Thromb Hemost; 2003 Jun; 29(3):317-20. PubMed ID: 12888936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fibrinolytic system of animals repeatedly and chronically administered plasminogen tissue activator].
    Shimonaeva EE; Liutova LV; Andreenko GV
    Vopr Med Khim; 1981; 27(6):823-8. PubMed ID: 7199779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
    Joseph IB; Nelson JB; Denmeade SR; Isaacs JT
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Localization of blood coagulation factors in situ in pancreatic carcinoma.
    Wojtukiewicz MZ; Rucinska M; Zacharski LR; Kozlowski L; Zimnoch L; Piotrowski Z; Kudryk BJ; Kisiel W
    Thromb Haemost; 2001 Dec; 86(6):1416-20. PubMed ID: 11776308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Levels of plasminogen and alpha 2-antiplasmin in blood of patients with prostatic tumor].
    Zietek Z; Iwan-Zietek I; Kotschy M; Tyloch F
    Pol Tyg Lek; 1996 Feb; 51(6-9):86-8. PubMed ID: 8756739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of prolonged exercise on the components of the blood fibrinolytic enzyme system.
    Bennett NB; Ogston CM; Ogston D
    J Physiol; 1968 Sep; 198(2):479-85. PubMed ID: 5698282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Metastasis of cancer and blood coagulation system].
    Shimada N; Nakagawa Y
    Nihon Ishikai Zasshi; 1969 Dec; 62(11):1097-102. PubMed ID: 4243734
    [No Abstract]   [Full Text] [Related]  

  • 35. Response of plasma fibrinogen and plasminogen to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancer.
    Seal US; Doe RP; Byar DP; Corle DK
    Cancer; 1976 Sep; 38(3):1108-17. PubMed ID: 182348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteolytic and fibrinolytic factors in the human prostate.
    Coune A; Brassinne C; Nijs M
    Thromb Haemost; 1979 May; 41(3):628-30. PubMed ID: 462427
    [No Abstract]   [Full Text] [Related]  

  • 37. Plasminogen activator in prostatic tumors of Nb rats.
    Rennie PS; Bruchovsky N; Noble RL; Mo S
    Biochim Biophys Acta; 1980 Oct; 632(3):437-43. PubMed ID: 6998504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The fibrinolytic enzyme system in hepatic cirrhosis and malignant metastases.
    Ogston D; Bennett NB; Ogston CM
    J Clin Pathol; 1971 Dec; 24(9):822-6. PubMed ID: 5139989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Separation and study of the range of plasminogen isoforms in patients with prostate cancer.
    Shin EF; Vodolazhsky DI; Golikov AY; Belova TN; Boyko NV; Zimakov DV; Cherkasova EN; Kogan MI; Chibichian MB; Moshkovskii SA; Tarasov VA; Matishov DG
    Biochemistry (Mosc); 2012 Sep; 77(9):1065-71. PubMed ID: 23157267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrinolytic activity and haemagglutination inhibition immunoassays.
    Gormsen J
    Scand J Haematol; 1970; 7(4):261-73. PubMed ID: 4991073
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.